BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

KORU Medical Submits FDA 510k For FreedomEDGE Use With PHESGO In HER2 Positive Breast Cancer

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on t...

January 01, 2026 | News

StimLabs Secures FDA 510k Clearance For Theracor Advancing Wound Care Innovation

StimLabs announces that the U.S. Food & Drug Administration (FDA) has granted 510(k) clearance for Theracor, the first human umbilical cord-derived med...

December 31, 2025 | News

EMA CHMP Backs Gotenfia Golimumab Biosimilar Advancing STADA and Bio Thera European Strategy

Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera and to be marke...

December 30, 2025 | News

Medtronic Files For MiniMed IPO As Diabetes Business Prepares For Public Market Separation

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that its Diabetes business, which as previously announced will operate under...

December 29, 2025 | News

Abbott Secures FDA Approval For Volt PFA System, Advancing Atrial Fibrillation Treatment In The United States

Abbott's Volt™ PFA System, the latest generation of cardiac ablation technology, is designed for people battling heart rhythm d...

December 29, 2025 | News

Niowave Extends Actinium 225 Supply Agreement With AstraZeneca To Support Next Generation Cancer Therapies

Niowave will expand its agreement to supply Actinium-225, a highly promising medical isotope, to AstraZeneca 10-year supply agreement ...

December 29, 2025 | News

Mondego Bio Selects ZE00 0388 As Lead Clinical Candidate And Prepares For Phase One Entry In 2026

Mondego Bio, a clinical-stage biotechnology company developing next-generation small-molecule immuno-oncology therapies, today announced the formal selecti...

December 25, 2025 | News

Enveda Advances Third Asset Into The Clinic As FDA Clears IND For ENV 6946 In Inflammatory Bowel Disease

Enveda achieves a significant milestone with three assets now in clinical development, further validating its platform’s ability to deliver differe...

December 25, 2025 | News

Solventum Completes Acquisition Of Acera Surgical To Strengthen MedSurg And Wound Care Portfolio

Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space in acute care settings in the U.S. Accelerates Solventum's bu...

December 24, 2025 | News

Bioeq And Zydus Secure USFDA Approval For Interchangeable Lucentis Biosimilar NUFYMCO

Bioeq AG ("Bioeq"), a Swiss biopharmaceutical company, and Zydus Lifesciences Limited ("Zydus"), an innovation-led life-sciences company with an internatio...

December 24, 2025 | News

NeuroSense Reports Clean Safety Profile From Phase 2 PrimeC Study In Alzheimer’s Disease

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for&nbs...

December 24, 2025 | News

Jacobio Pharma Strikes Global Deal With AstraZeneca For Pan KRAS Inhibitor JAB 23E73

Jacobio Pharma announced that it has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73. AstraZeneca will receive ...

December 23, 2025 | News

Meiji Seika Pharma Partners With MBC BioLabs To Strengthen Global Biotech Innovation

-Meiji Seika Pharma Co., Ltd. announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting ...

December 22, 2025 | News

Atom Therapeutics Secures FDA Approval To Advance Phase II Trial Of ABP 745 In Atherosclerosis

Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA ...

December 18, 2025 | News

Stay Connected